Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of an AI-Based Metastasis Prediction Model Using Prostate Cancer Biopsy Pathology

NCT07660276 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT07660276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07660276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of an AI-Based Metastasis Prediction Model Using Prostate Cancer Biopsy Pathology
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 8, 2026
Completion date
August 1, 2026
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic